Centurion+ Patent Holders as of May 7, 2024

Paul Lubock

Vice President and one of the Co-Founders of Inceptus Medical, a medical device incubator founded in June 2011.

Patent №: 11974910 (May 7, 2024) – System for treating embolism and associated devices and methods. The process involves positioning a catheter near a clot in a blood vessel, connecting a pressure source to the catheter with a valve-equipped tubing system, charging a vacuum with the valve closed, and then opening the valve to aspirate the clot into the catheter.

Patent №: 11974909 (May 7, 2024) – System for treating embolism and associated devices and methods. The method involves positioning a catheter near a clot in a blood vessel, connecting a pressure source to the catheter through tubing with a valve, charging a vacuum while the valve is closed, and then opening the valve to apply the vacuum. This aspirates at least part of the clot into the catheter.

Hany Mohamed Abd El-Lateef Ahmed

Dr. Hany is now Guest Editor for Molecules and Polymers Journals (MDPI).

Patent №: 11976055 (May 7, 2024) – 2-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-3-ol as an antitumor and antimicrobial compound.

Patent №: 11976051 (May 7, 2024) – N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide as an antimicrobial compound.

Patent №: 11976050 (May 7, 2024) – N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-1-naphthimidamide as an antimicrobial compound

Patent №: 11976048 (May 7, 2024) – 1-(2-hydroxybenzylideneamino)-5-phenylimidazolidine-2,4-dione as an antimicrobial compound.

Patent №: 11976047 (May 7, 2024) – 4,5-bis(4-bromo-phenyl)-1-hexyl-2-(2- methoxyphenyl)-1H-imidazole as an antimicrobial compound.

Patent №: 11976046 (May 7, 2024) – 4-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)benzoic acid as an antimicrobial compound.

Patent №: 11976045 (May 7, 2024) – 3-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)propanoic acid as an antimicrobial compound.

Patent №: 11976043 (May 7, 2024) – 3-cyano-2-ethoxy-9-(2-nitrobenzylidene)-4-(2-nitrophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine as an antimicrobial compound

Patent №: 11976042 (May 7, 2024) – 9-(5-bromo-2-hydroxyphenyl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound

Patent №: 11976041 (May 7, 2024) – 9-(5-bromo-2-hydroxyphenyl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound

Patent №: 11976033 (May 7, 2024) – Selective organoselenium-based ligands for the dispersive liquid-liquid microextraction of copper and zinc ions from real samples. Novel organoselenium ligands have been developed for selectively detecting metal ions in samples. These ligands are employed in a streamlined dispersive liquid-liquid microextraction method for copper and zinc ions, featuring reduced extraction time, fewer and lower volumes of organic solvents, simple operation, and high enrichment efficiency.

Patent №: 11976031 (May 7, 2024) – 8-((4-hydroxy-3-methylphenyl)diazenyl)naphthalene-1,3-disulfonic acid as an antioxidant compound.

Patent №: 11974995 (May 7, 2024) – 6′-(4-bromophenyl)-2′-methoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound.

Patent №: 11974571 (May 7, 2024) – 3-5-dinitro-N-(pyrimidin-2-ylcarbamothioyl)benzamide as an eco-friendly insecticidal agent against(boisd.).

Patent №: 11974570 (May 7, 2024) – 1,3-bis(naphthalen-1-yloxy)propan-2-one an eco-friendly insecticidal agent against(Boisd.).